Stay updated with breaking news from Nasdaq Imrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immuneering Co. (NASDAQ:IMRX – Get Free Report) Director Peter Feinberg acquired 25,000 shares of the firm’s stock in a transaction on Friday, March 22nd. The shares were bought at an average cost of $2.55 per share, for a total transaction of $63,750.00. Following the completion of the acquisition, the director now directly owns 111,766 shares […]
Immuneering Co. (NASDAQ:IMRX – Get Free Report) insider Harold Eugene Brakewood bought 3,900 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was bought at an average cost of $2.57 per share, for a total transaction of $10,023.00. Following the completion of the purchase, the insider now directly owns […]
Tucker Asset Management LLC bought a new stake in Immuneering Co. (NASDAQ:IMRX – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 11,036 shares of the company’s stock, valued at approximately $112,000. A number of other institutional investors also […]
Immuneering Co. (NASDAQ:IMRX – Get Free Report)’s share price rose 18% during trading on Tuesday . The stock traded as high as $7.21 and last traded at $7.03. Approximately 54,309 shares changed hands during trading, a decline of 24% from the average daily volume of 71,238 shares. The stock had previously closed at $5.96. Analyst […]
Immuneering (NASDAQ:IMRX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities research analysts at Oppenheimer in a report released on Tuesday, Benzinga reports. They presently have a $25.00 price objective on the stock. Oppenheimer’s price target indicates a potential upside of 150.00% from the stock’s previous close. Several other brokerages have also […]